4//SEC Filing
Cohen Darrel P. 4
Accession 0001209191-23-046578
CIK 0001061027other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 4:46 PM ET
Size
8.8 KB
Accession
0001209191-23-046578
Insider Transaction Report
Form 4
Cohen Darrel P.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-16+235,000→ 235,000 totalExercise: $1.23Exp: 2033-08-16→ Common Stock (235,000 underlying) - Award
Stock Option (Right to Buy)
2023-08-16+265,000→ 265,000 totalExercise: $1.23Exp: 2033-08-16→ Common Stock (265,000 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
- [F2]Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Equity Incentive Plan through each such date. The Vesting Commencement Date is August 7, 2023.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001989794
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 4:46 PM ET
- Size
- 8.8 KB